CETP and coronary artery disorder: Polymorphisms in other genes such as CD14, Interleukin‐6, methylenetetrahydrofolate reductase, intercellular adhesion molecule‐1, ATP‐binding cassette transporter A1, apo A5, FgB and CETP, plasminogen activator inhibitor‐1 may also affect CAD risk 33, 34, 35, 36, 37, 38, 39.